These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 26579986)

  • 21. Echolucency of the carotid artery intima-media complex and intima-media thickness have different cardiovascular risk factor relationships: the Women's Interagency HIV Study.
    Jung M; Parrinello CM; Xue X; Mack WJ; Anastos K; Lazar JM; Selzer RH; Shircore AM; Plankey M; Tien P; Cohen M; Gange SJ; Hodis HN; Kaplan RC
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25699995
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diagnosis of subclinical atherosclerosis in HIV-infected patients: higher accuracy of the D:A:D risk equation over Framingham and SCORE algorithms.
    Serrano-Villar S; Estrada V; Gómez-Garre D; Ávila M; Fuentes-Ferrer M; San RJ; Soriano V; Sánchez-Parra C; Sainz T; Fernández-Cruz A
    Eur J Prev Cardiol; 2014 Jun; 21(6):739-48. PubMed ID: 22718798
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Markers of inflammation and CD8 T-cell activation, but not monocyte activation, are associated with subclinical carotid artery disease in HIV-infected individuals.
    Longenecker CT; Funderburg NT; Jiang Y; Debanne S; Storer N; Labbato DE; Lederman MM; McComsey GA
    HIV Med; 2013 Jul; 14(6):385-90. PubMed ID: 23332012
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Reduced CD14 expression on classical monocytes and vascular endothelial adhesion markers independently associate with carotid artery intima media thickness in chronically HIV-1 infected adults on virologically suppressive anti-retroviral therapy.
    Barbour JD; Jalbert EC; Chow DC; Gangcuangco LM; Norris PJ; Keating SM; Heitman J; Nagamine L; Seto T; Ndhlovu LC; Nakamoto BK; Hodis HN; Parikh NI; Shikuma CM
    Atherosclerosis; 2014 Jan; 232(1):52-8. PubMed ID: 24401216
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Albuminuria as a marker of cardiovascular risk in HIV-infected individuals receiving stable antiretroviral therapy.
    Tongma C; Shikuma CM; Nakamoto BK; Kallianpur KJ; Umaki TM; Barbour JD; Ndhlovu L; Parikh NI; Chow DC
    Hawaii J Med Public Health; 2013 Sep; 72(9 Suppl 4):34-8. PubMed ID: 24052917
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of the tissue factor and its inhibitor in the development of subclinical atherosclerosis in people living with HIV.
    Barska K; Kwiatkowska W; Knysz B; Arczyńska K; Karczewski M; Witkiewicz W
    PLoS One; 2017; 12(7):e0181533. PubMed ID: 28749986
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging.
    Floris-Moore M; Fayad ZA; Berman JW; Mani V; Schoenbaum EE; Klein RS; Weinshelbaum KB; Fuster V; Howard AA; Lo Y; Schecter AD
    AIDS; 2009 May; 23(8):941-9. PubMed ID: 19318907
    [TBL] [Abstract][Full Text] [Related]  

  • 28. HIV Infection and Carotid Artery Intima-media Thickness: Pooled Analyses Across 5 Cohorts of the NHLBI HIV-CVD Collaborative.
    Hanna DB; Guo M; Bůžková P; Miller TL; Post WS; Stein JH; Currier JS; Kronmal RA; Freiberg MS; Bennett SN; Shikuma CM; Anastos K; Li Y; Tracy RP; Hodis HN; Delaney JA; Kaplan RC
    Clin Infect Dis; 2016 Jul; 63(2):249-56. PubMed ID: 27118787
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Premature atherosclerosis in HIV-infected individuals--focus on protease inhibitor therapy.
    Depairon M; Chessex S; Sudre P; Rodondi N; Doser N; Chave JP; Riesen W; Nicod P; Darioli R; Telenti A; Mooser V;
    AIDS; 2001 Feb; 15(3):329-34. PubMed ID: 11273212
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relations between cardiovascular risk estimates and subclinical atherosclerosis in naive HIV patients: results from the HERMES study.
    De Socio GV; Martinelli C; Ricci E; Orofino G; Valsecchi L; Vitiello P; Martinelli L; Quirino T; Maggi P; Bonfanti P;
    Int J STD AIDS; 2010 Apr; 21(4):267-72. PubMed ID: 20378899
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of Lower Adiponectin Plasma Levels, Increased Age and Smoking with Subclinical Atherosclerosis in Patients with HIV-1 Infection.
    Bellinati PQ; Alfieri DF; Flauzino T; Junior PFG; Rossi DJ; Breganó JW; Simão ANC; de Almeida ERD; Lozovoy MAB; Reiche EMV
    Curr HIV Res; 2020; 18(4):292-306. PubMed ID: 32516102
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Two-year treatment with rosuvastatin reduces carotid intima-media thickness in HIV type 1-infected patients receiving highly active antiretroviral therapy with asymptomatic atherosclerosis and moderate cardiovascular risk.
    Calza L; Manfredi R; Colangeli V; Trapani FF; Salvadori C; Magistrelli E; Danese I; Verucchi G; Serra C; Viale P
    AIDS Res Hum Retroviruses; 2013 Mar; 29(3):547-56. PubMed ID: 23098891
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Carotid intimal medial thickness in human immunodeficiency virus-infected women: effects of protease inhibitor use, cardiac risk factors, and the metabolic syndrome.
    Johnsen S; Dolan SE; Fitch KV; Kanter JR; Hemphill LC; Connelly JM; Lees RS; Lee H; Grinspoon S
    J Clin Endocrinol Metab; 2006 Dec; 91(12):4916-24. PubMed ID: 17003092
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased carotid intima media thickness and cardiac biomarkers in HIV infected children.
    McComsey GA; O'Riordan M; Hazen SL; El-Bejjani D; Bhatt S; Brennan ML; Storer N; Adell J; Nakamoto DA; Dogra V
    AIDS; 2007 May; 21(8):921-7. PubMed ID: 17457085
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Arterial stiffness and carotid intima-media thickness in HIV infected patients.
    Papita A; Albu A; Fodor D; Itu C; Cârstina D
    Med Ultrason; 2011 Jun; 13(2):127-34. PubMed ID: 21655539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Progression of carotid artery intima-media thickening in HIV-infected and uninfected adults.
    Currier JS; Kendall MA; Henry WK; Alston-Smith B; Torriani FJ; Tebas P; Li Y; Hodis HN
    AIDS; 2007 May; 21(9):1137-45. PubMed ID: 17502724
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Risk of cardiovascular disease in a cohort of HIV-infected adults: a study using carotid intima-media thickness and coronary artery calcium score.
    Mangili A; Gerrior J; Tang AM; O'Leary DH; Polak JK; Schaefer EJ; Gorbach SL; Wanke CA
    Clin Infect Dis; 2006 Dec; 43(11):1482-9. PubMed ID: 17083026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Longitudinal changes in carotid intima-media thickness and cardiovascular risk factors in human immunodeficiency virus-infected children and young adults compared with healthy controls.
    Ross AC; Storer N; O'Riordan MA; Dogra V; McComsey GA
    Pediatr Infect Dis J; 2010 Jul; 29(7):634-8. PubMed ID: 20589981
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Non-classical monocytes predict progression of carotid artery bifurcation intima-media thickness in HIV-infected individuals on stable antiretroviral therapy.
    Chow DC; Kagihara JM; Zhang G; Souza SA; Hodis HN; Li Y; Mitchell BI; Nakamoto BK; Kallianpur KJ; Keating SM; Norris PJ; Kohorn LB; Ndhlovu LC; Shikuma CM
    HIV Clin Trials; 2016 May; 17(3):114-22. PubMed ID: 27125366
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Potential cardiovascular disease risk markers among HIV-infected women initiating antiretroviral treatment.
    Kaplan RC; Landay AL; Hodis HN; Gange SJ; Norris PJ; Young M; Anastos K; Tien PC; Xue X; Lazar J; Parrinello CM; Benning L; Tracy RP
    J Acquir Immune Defic Syndr; 2012 Aug; 60(4):359-68. PubMed ID: 22592585
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.